Co-administration of berberine and plant stanols synergistically reduces plasma cholesterol in rats

Atherosclerosis

Volumn 201, Issue 1, 2008, Pages 101-107

  Jia, Xiaoming ^a   Chen, Yanfeng ^a,b   Zidichouski, Jeffrey ^a   Zhang, Junzeng ^a   Sun, Changhao ^b   Wang, Yanwen ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; Liver cholesterol; Plant stanols; Plasma cholesterol; Plasma triacylglyceride; Rats; Toxicity

Indexed keywords

BERBERINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; STANOL ESTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD INTAKE; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTICHOLESTEREMIC AGENTS; BERBERINE; CHOLESTEROL; DIET, ATHEROGENIC; DRUG THERAPY, COMBINATION; LIPOPROTEINS; MALE; PHYTOSTEROLS; RATS; RATS, SPRAGUE-DAWLEY; SITOSTEROLS; TRIGLYCERIDES;

EID: 52049116419     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.03.008     Document Type: Article

References (70)

1. Bays H., and Stein E.A. Pharmacotherapy for dyslipidaemia-current therapies and future agents. Exp Opin Pharmacother 4 (2003) 1901-1938
2. Kannel W.B., Castelli W.P., Gordon T., and McNamara P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 74 (1971) 1-12
3. Chan D.C., Barrett P.H., and Watts G.F. Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders. Curr Opin Lipidol 17 (2006) 28-36
4. Merkel M., Velez-Carrasco W., Hudgins L.C., and Breslow J.L. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice. Proc Natl Acad Sci USA 98 (2001) 13294-13299
5. Martin M.J., Hulley S.B., Browner W.S., Kuller L.H., and Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 2 (1986) 933-936
6. Klag M.J., Ford D.E., Mead L.A., et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328 (1993) 313-318
7. Jeppesen J., Hansen T.W., Rasmussen S., Ibsen H., and Torp-Pedersen C. Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study. Atherosclerosis 189 (2006) 369-374
8. Egger M., Smith G.D., Pfluger D., Altpeter E., and Elwood P.C. Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error. Atherosclerosis 143 (1999) 275-284
9. Assmann G. Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management. Am J Cardiol 87 (2001) 2B-7B
10. Le N.A., and Walter M.F. The role of hypertriglyceridemia in atherosclerosis. Curr Atheroscler Rep 9 (2007) 110-115
11. Grundy S.M. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 81 (1998) 18B-25B
12. Vanstone C.A., Raeini-Sarjaz M., Parsons W.E., and Jones P.J. Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am J Clin Nutr 76 (2002) 1272-1278
13. Kong W., Wei J., Abidi P., et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10 (2004) 1344-1351
14. Rodenburg J., Vissers M.N., Daniels S.R., Wiegman A., and Kastelein J.J. Lipid-lowering medications. Pediatr Endocrinol Rev 2 Suppl. 1 (2004) 171-180
15. Shepherd J. Lipids in health and disease. Biochem Soc Trans 32 (2004) 1051-1056
16. Rutishauser J. The role of statins in clinical medicine-LDL-cholesterol lowering and beyond. Swiss Med Wkly 136 (2006) 41-49
17. Ezetimibe: new preparation. A cholesterol-lowering drug with no clinical advantage. Prescrire Int 2004;13:176-9.
18. Magalhaes M.E. Mechanisms of rhabdomyolysis with statins. Arq Bras Cardiol 85 Suppl. 5 (2005) 42-44
19. Thompson G.R. Poor responders to statins: a potential target fro stanol esters. Eur Heart J Suppl 1 (1999) S114-S117
20. Varady K.A., Ebine N., Vanstone C.A., Parsons W.E., and Jones P.J. Plant sterols and endurance training combine to favorably alter plasma lipid profiles in previously sedentary hypercholesterolemic adults after 8 wk. Am J Clin Nutr 80 (2004) 1159-1166
21. Korpela R., Tuomilehto J., Hogstrom P., et al. Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols. Eur J Clin Nutr 60 (2006) 633-642
22. Acuff R.V., Cai D.J., Dong Z.P., and Bell D. The lipid lowering effect of plant sterol ester capsules in hypercholesterolemic subjects. Lipids Health Dis 6 (2007) 11
23. Jones P.J., Raeini-Sarjaz M., Ntanios F.Y., et al. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 41 (2000) 697-705
24. Miettinen T.A., Vuoristo M., Nissinen M., Jarvinen H.J., and Gylling H. Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am J Clin Nutr 71 (2000) 1095-1102
25. Ostlund Jr. R.E., Spilburg C.A., and Stenson W.F. Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans. Am J Clin Nutr 70 (1999) 826-831
26. Abidi P., Chen W., Kraemer F.B., Li H., and Liu J. The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms. J Lipid Res 47 (2006) 2134-2147
27. Abidi P., Zhou Y., Jiang J.D., and Liu J. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler Thromb Vasc Biol 25 (2005) 2170-2176
28. Hendriks H.F., Weststrate J.A., van Vliet T., and Meijer G.W. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 53 (1999) 319-327
29. Hallikainen M.A., and Uusitupa M.I. Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr 69 (1999) 403-410
30. Jones P.J., Ntanios F.Y., Raeini-Sarjaz M., and Vanstone C.A. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am J Clin Nutr 69 (1999) 1144-1150
31. Katan M.B., Grundy S.M., Jones P., et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78 (2003) 965-978
32. Normen L., Shaw C.A., Fink C.S., and Awad A.B. Combination of phytosterols and omega-3 fatty acids: a potential strategy to promote cardiovascular health. Curr Med Chem Cardiovasc Hematol Agents 2 (2004) 1-12
33. Gylling H., and Miettinen T.A. Cholesterol reduction by different plant stanol mixtures and with variable fat intake. Metabolism 48 (1999) 575-580
34. Weststrate J.A., and Meijer G.W. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 52 (1998) 334-343
35. Patch C.S., Tapsell L.C., and Williams P.G. Plant sterol/stanol prescription is an effective treatment strategy for managing hypercholesterolemia in outpatient clinical practice. J Am Diet Assoc 105 (2005) 46-52
36. Pelletier X., Belbraouet S., Mirabel D., et al. A diet moderately enriched in phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans. Ann Nutr Metab 39 (1995) 291-295
37. Hallikainen M., Lyyra-Laitinen T., Laitinen T., et al. Endothelial function in hypercholesterolemic subjects: effects of plant stanol and sterol esters. Atherosclerosis 188 (2005) 425-432
38. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28 (1982) 1379-1388
39. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
40. Wang Y., Jones P.J., Ausman L.M., and Lichtenstein A.H. Soy protein reduces triglyceride levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects. Atherosclerosis 173 (2004) 269-275
41. Ren L.H., Vasil'ev A.V., Orkehov A.N., Tertov V.V., and Tutel'ian V.A. Evaluation of the antiatherosclerotic properties of natural compounds of plant origin on cell cultures of the human aortic intima. Farmakol Toksikol 52 (1989) 44-46
42. Hattori T., Furuta K., Nagao T., et al. Studies on the antinephritic effect of plant components. (4). Reduction of protein excretion by berberine and coptisine in rats with original-type anti-GBM nephritis. Jpn J Pharmacol 59 (1992) 159-169
43. Leng S.H., Lu F.E., and Xu L.J. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 25 (2004) 496-502
44. Suckling K.E., and Jackson B. Animal models of human lipid metabolism. Prog Lipid Res 32 (1993) 1-24
45. Kris-Etherton P.M., and Dietschy J. Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies. Am J Clin Nutr 65 (1997) S1590-S1596
46. Bergen W.G., and Mersmann H.J. Comparative aspects of lipid metabolism: impact on contemporary research and use of animal models. J Nutr 135 (2005) 2499-2502
47. Tang L.Q., Wei W., Chen L.M., and Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 108 (2006) 109-115
48. Hayes K.C., Pronczuk A., Wijendran V., and Beer M. Free phytosterols effectively reduce plasma and liver cholesterol in gerbils fed cholesterol. J Nutr 132 (2002) 1983-1988
49. Ellegard L., Andersson H., and Bosaeus I. Rapeseed oil, olive oil, plant sterols, and cholesterol metabolism: an ileostomy study. Eur J Clin Nutr 59 (2005) 1374-1378
50. Hayes K.C., Pronczuk A., Wijendran V., and Beer M. Free phytosterols facilitate excretion of endogenous cholesterol in gerbils. J Nutr Biochem 16 (2005) 305-311
51. Lee Y.S., Kim W.S., Kim K.H., et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55 (2006) 2256-2264
52. Brusq J.M., Ancellin N., Grondin P., et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 47 (2006) 1281-1288
53. Choi B.H., Ahn I.S., Kim Y.H., et al. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp Mol Med 38 (2006) 599-605
54. Jones P.J., MacDougall D.E., Ntanios F., and Vanstone C.A. Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol 75 (1997) 217-227
55. Ling W.H., and Jones P.J. Enhanced efficacy of sitostanol-containing versus sitostanol-free phytosterol mixtures in altering lipoprotein cholesterol levels and synthesis in rats. Atherosclerosis 118 (1995) 319-331
56. Lau V.W., Journoud M., and Jones P.J. Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons. Am J Clin Nutr 81 (2005) 1351-1358
57. Wang Y.W., Jones P.J., Pischel I., and Fairow C. Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters. Lipids 38 (2003) 165-170
58. Gores G.J., Herman B., and Lemasters J.J. Plasma membrane bleb formation and rupture: a common feature of hepatocellular injury. Hepatology 11 (1990) 690-698
59. Van Hoof V.O., Deng J.T., and De Broe M.E. How do plasma membranes reach the circulation?. Clin Chim Acta 266 (1997) 23-31
60. Buse J.B., Klonoff D.C., Nielsen L.L., et al. Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials. Clin Ther 29 (2007) 139-153
61. Arrese M., Pizarro M., Solis N., Koenig C., and Accatino L. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration. Biochem Pharmacol 50 (1995) 1223-1232
62. Kim T.S., Kang B.Y., Cho D., and Kim S.H. Induction of interleukin-12 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Th1 response. Immunology 109 (2003) 407-414
63. Kang B.Y., Chung S.W., Cho D., and Kim T.S. Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid. Biochem Pharmacol 63 (2002) 1901-1910
64. Fukuda K., Hibiya Y., Mutoh M., et al. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 66 (1999) 227-233
65. Bradford P.G., and Awad A.B. Phytosterols as anticancer compounds. Mol Nutr Food Res 51 (2007) 161-170
66. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8 (2003) 223-246
67. Ntanios F.Y., MacDougall D.E., and Jones P.J. Gender effects of tall oil versus soybean phytosterols as cholesterol-lowering agents in hamsters. Can J Physiol Pharmacol 76 (1998) 780-787
68. Ostlund Jr. R.E. Phytosterols and cholesterol metabolism. Curr Opin Lipidol 15 (2004) 37-41
69. Reagan-Shaw S., Nihal M., and Ahmad N. Dose translation from animal to human studies revisited. FASEB J 22 (2008) 659-661
70. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123 (1993) 1939-1951